Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasm Metastasis × Genetic Testing × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Prostatic Neoplasms 3 Urogenital Neoplasms 2 Pancreatic Neoplasms 2 Endometrial Neoplasms 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1 Wilms Tumor 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neurofibromatosis 1 1 Neoplasms, Unknown Primary 1 Neoplasm Metastasis 1 Kidney Neoplasms 1 Hot Flashes 1 Head and Neck Neoplasms 1 Genetic Predisposition to Disease 1 Dyslexia 1 Digestive System Neoplasms 1 Depression 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Advanced Malignant Neoplasm 1

Interventions

Gemcitabine 57 Capecitabine 51 Paclitaxel 49 Fluorouracil 47 Oxaliplatin 45 Bevacizumab 45 Leucovorin 39 Docetaxel 39 Nivolumab 37 Carboplatin 32 Cisplatin 31 Irinotecan 30 pembrolizumab 28 Cetuximab 28 Radiosurgery 26 Trastuzumab 25 Radiotherapy 22 Everolimus 20 Sorafenib 18 Pemetrexed 17 Cyclophosphamide 17 Prednisone 16 Panitumumab 16 Ipilimumab 16 Doxorubicin 15 Zoledronic Acid 14 Erlotinib Hydrochloride 14 Albumin-Bound Paclitaxel 14 Lapatinib 13 Fulvestrant 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01460186 2019-01-15

StoRM

Centre Leon Berard

Phase NA Completed

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡